Resveratrol Modulates Lung Cancer-Associated Hub Genes Identified by Integrated Bioinformatics, Single-Cell Analysis, Molecular Docking, and Experimental Validation

Jing-Hua Yang Han-Xiu Wei Jie Li Jun Chen

Aug 2026 · Cell Biochemistry and Biophysics · Vol 84, pp. 4495 - 4522 · 0 citations · 49 references

Medicine

TL;DR

This study identified five lung cancer-associated hub genes and provided preliminary evidence that resveratrol may modulate their expression, and provides a multi-level molecular framework for further investigation of resveratrol-responsive networks in lung cancer.

DOI PubMed Semantic Scholar

View source

Similar papers

Open access Aug 2026

Integrated bioinformatics and molecular docking identify novel key genes, pathways, and potential candidate drugs in papillary thyroid carcinoma

The findings of the current study offer that FN1, DPP4, CD36, KIT, ITGA2 and hsa-miR-124-3p may be novel biosignatures and therapeutic targets for PTC.

Mehdi Koushki, M. Farahani, Nasrin Amiri-Dashatan et al. · Journal of Genetic Engineeri... · 0 citations

Jul 2026

Transcriptomic network analysis and functional evidence identify a candidate EMT hub signature associated with nasopharyngeal carcinoma progression.

Integrative analysis identifies VIM, SNAI1, ZEB1, and FN1 as a candidate EMT-associated hub signature linked with NPC progression, prognosis, and drug response patterns, suggesting that this EMT hub network may have potential value as a prognostic biomarker panel and as a putative therapeutic vulnerability requiring fu...

Xiao-Peng Sun, Bo Kou · Naunyn-Schmiedeberg's Archiv... · 0 citations

Jul 2026

Investigating the mechanisms of malignant progression in colorectal cancer using weighted gene co-expression network analysis and machine learning

The TFAP4-CDK1 axis is established as a critical driver of malignant progression in CRC and Targeting this pathway could lead to the development of novel interventions for CRC.

Song Zheng, Lei Meng, Xiaoye Fan et al. · Journal of Molecular Histolo... · 0 citations

Open access Aug 2026

Integrated Bioinformatic and Experimental Analysis Reveals the Molecular Mechanisms Underlying KDM1B/LSD2 Inhibition as a Therapeutic Strategy in Human Lung Adenocarcinoma.

Findings highlight KDM1B as a valuable therapeutic target in lung adenocarcinoma and emphasize its key role in lung cancer development.

K. Muthiah, S. Natarajan, U. Dhawan et al. · Journal of Cellular Biochemi... · 0 citations

Open access Jul 2026

Integrative Bioinformatics and Experimental Validation Reveal that METTL9 Drives Lung Adenocarcinoma Progression via TGF-β/Smad-Mediated EMT Activation.

The results indicate that METTL9 may contribute to LUAD progression and EMT, potentially in relation to the TGF-β/Smad signaling pathway, potentially in relation to the TGF-β/Smad signaling pathway.

Chen Gong, Yu-Yan Chen, Yuchen Xie et al. · Frontiers in Bioscience · 0 citations

Open access Jul 2026

Integrated Bioinformatics and RT-qPCR Validation Identify Candidate Biomarkers Associated with EGFR-TKI Resistance in EGFR-Mutant Lung Adenocarcinoma

Integrated bioinformatics analysis identified TGFA, DDIT4, and SOX9 as candidate genes associated with EGFR-TKI resistance in EGFR-mutant lung adenocarcinoma, providing a basis for further investigation of resistance-associated biomarkers.

M. A. Hanif, Fadilah, N. Sutandyo et al. · BioMedInformatics · 0 citations